IRCT20220211053992N29招募中Unknown
In vivo bioequivalence study of Effavirenz/Emtricitabine/Tenofovir (600/200/300) manufactured by Bakhtar Bioshimi Co. compared with innovator product
试验速览
- 阶段
- Unknown
- 状态
- 招募中
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 59 years（—）
- 性别
- All
入选标准
- •General Health (in terms of Liver, Heart and Kidney)
排除标准
- •History of cardiovascular disease, liver and kidney disease
- •Alcohol and drug addiction
- •History of drug allergy
研究者
相似试验
已完成
4 期
Bioequivalence Study of Two Formulatiosns With the Asscociaton of Efavirenz, Emtricitabine and TenofovirHealthyNCT03309566Laboratorio Elea Phoenix S.A.24
尚未招募
1 期
Bioequivalence of EfavirenzPatients seropositive to Human Immunodeficiency Virus (HIV)Lentiviruses InfectionsRetroviridae InfectionsRNA Viruses InfectionsSexually Transmitted Diseases, ViralImmunologic Deficiency SyndromesImmune System DiseasesVirus DiseasesSexually Transmitted DiseasesHIV InfectionsRPCEC00000264Center for Pharmaceutical Research and Development, Havana, Cuba.30
招募中
不适用
In-vivo Bioequivalence Test of Empagliflozin tablets with brand drug (JARDIANCE® 25 mg, Boehringer Ingelheim , Germany)Bio equivalence test.IRCT20200105046010N49Pars Darou Pharm. Co.24
招募中
Unknown
Bioequivalence Study of Empagliflozin/Metformin 5/500 mgThis study is performed on healthy volunteers and drug concentration in plasma is determined..IRCT20200105046010N95Kharazmi Pharmacy24
招募中
不适用
In-vivo Bioequivalence Test of Favipiravir® tablet with brand drugs (AVIGAN® 200mgTAYOMA Chemical Ind. Co).IRCT20200105046010N30ABIDI Pharmaceutical Company24